Rare disease Background:
Background
Recently, synchronous multiple lung cancer (SMPLC) has sometimes been detected due to improvements in radiological imaging. The original criteria for multiple lung cancers were first reported in 1932 by Warren and Gates [1] , who stated each tumor must represent a definite picture of carcinoma, each tumor must be distinct, and that the probability of 1 lesion metastasizing from another must be excluded. In addition, Martini and Melamed [2] indicated that SMPLC requires the existence of tumors in different portions of an organ and different histological types, or the existence in a different lobe or segment.
The occurrence of squamous cell carcinoma with squamous cell carcinoma has been the most frequent type of synchronous double lung cancer [3, 4] . To the best of our knowledge, there have been no reported cases dealing with synchronous double primary lung cancer presenting with pleomorphic carcinoma and adenocarcinoma. We herein report such a case.
Case Report
A 64-year-old male was referred to our institution for evaluation of an abnormal shadow on a chest X-ray in April 2012. He had been healthy with no symptoms and had an unremarkable medical and family history, and was a current smoker. The chest X-ray showed an abnormal shadow in the apex of the left lung ( Figure 1 ). Contrast-enhanced CT revealed a nodule with an irregular margin that measured 15 mm in the left S 1+2b (Figure 2A ). In addition, the image showed another nodule that measured 20 mm in the left S 3c ( Figure 2B ). Enlarged lymph nodes were not detected in the mediastinum. The levels of serum tumor markers such as CEA, CYFLA and ProGRP were within normal ranges. There were no other signs of distant metastasis based on a CT scan of the chest, abdomen, and pelvis, or by brain MRI.
We suspected that the lesions were primary lung cancers, although the diagnosis could not be confirmed by transbronchial lung biopsy. In May 2012, we performed left upper lobectomy, and a pathological diagnosis of lung cancer was confirmed based on the results of a flash-frozen section biopsy of the nodule in the left S 3c , although the biopsy of the nodule in the The patient received chemotherapy with carboplatin and pemetrexed, but it was not effective. Furthermore, it was difficult to continue the chemotherapy because his performance status worsened. He died on May 2013.
Discussion
The occurrence of SPMLC is rare, and the incidence of synchronous multiple primary lung cancers ranges from 1% to 7% according to clinical trials [2] . Among these cases, those of the bilateral type comprise 60-70%, while the unilateral type is been comparatively rare [5, 6] . With regard to the histological types of SPMLC, the occurrence of squamous cell carcinoma and squamous cell carcinoma has been the most common, followed by squamous cell carcinoma and small cell carcinoma, and squamous cell carcinoma and adenocarcinoma [3, 7] .
The prognosis of SMPLC remains unclear. Whereas the overall survival rate (OS) of patients diagnosed with SMPLC had been reported to be significantly lower than in patients with single primary lung cancers (SPLC) [8] , Yu et al. reported that there was no significant difference in OS between SPMLC and SPLC [9] . While tumor size is thought to an important predictor of OS in SMPLC [9, 10] , the presence of lymphovascular invasion and the histology of SMPLC do not significantly affect OS according to Yu et al. [11, 12] . However, the present case was associated with a very poor prognosis, despite the fact that the T stage of each tumor was T1a. This may be associated with the histology of 1 of the tumors, which was pleomorphic carcinoma, because the pathological examination of the gastric ulcer confirmed metastasis of the lung pleomorphic carcinoma, and the other metastasis was also thought to have originated from pleomorphic carcinoma. Pleomorphic carcinoma of the lung is rare, accounting for 0.3% to 1% of all lung malignancies [13] . Pleomorphic carcinoma was first classified as a carcinoma with pleomorphic, sarcomatoid, or sarcomatous elements by the World Health Organization in 1999, and in the 2003 Classification of Lung Cancers was defined as a poorly differentiated non-small cell carcinoma, which includes squamous cell carcinoma, adenocarcinoma, and large-cell carcinoma that contains spindle cells or giant cells, and cancers that contain at least 10% spindle cells or giant cell areas [14] .
Pulmonary pleomorphic carcinoma was associated with a poor prognosis in previous studies, even when early-stage disease was diagnosed and resected [15] . In addition, pulmonary pleomorphic carcinoma showed a poor response to chemotherapy [16] . The prognosis of affected patients is generally poorer than that of patients with other types of non-small cell lung
